Related Experiment Video

Updated: Jul 1, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Progress on potential strategies to target brain tumor stem cells

Xing-gang Mao1, Xiang Zhang, Hai-ning Zhen

  • 1Department of Neurosurgery, Xijing Institute of Clinical Neuroscience, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, People's Republic of China.

Cellular and Molecular Neurobiology
|September 11, 2008
PubMed

Insights

Brain tumor stem cells (BTSCs) drive tumor growth and resistance. Targeting BTSCs offers a promising strategy for effective brain tumor treatment by eliminating these resilient cells.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology
  • Molecular Therapeutics

Background:

  • Brain tumor stem cells (BTSCs) are crucial drivers of tumor growth, recurrence, and resistance to conventional therapies like radiotherapy and chemotherapy.
  • BTSCs share similarities with normal neural stem cells (NSCs), necessitating targeted eradication strategies to avoid collateral damage.

Purpose of the Study:

  • To review the challenges and advantages associated with targeting brain tumor stem cells (BTSCs).
  • To emphasize and discuss potential therapeutic strategies aimed at specifically eradicating BTSCs.

Main Methods:

  • Review of current literature on BTSCs, their characteristics, and their role in brain tumor progression.
  • Analysis of various therapeutic strategies targeting BTSCs, including surface markers, niche interactions, and signaling pathways.

Main Results:

  • Identification of BTSCs as key targets for overcoming treatment resistance and preventing tumor recurrence.
  • Emerging therapeutic strategies show promise in selectively eliminating BTSCs with minimal impact on normal neural stem cells.

Conclusions:

  • Targeting BTSCs is a critical approach for advancing brain tumor treatment efficacy.
  • Further research into specific BTSC vulnerabilities and targeted therapies is essential for clinical translation.

More Related Videos

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...